COMMUNIQUÉS West-GlobeNewswire

Albireo Granted Orphan Designation by European Commission For Lead Product Candidate A4250 for Treatment of Biliary Atresia
18/12/2018
Expands lead product candidate’s development potential in rare cholestatic liver diseases Provides 10 years market exclusivity upon approval plus 2 years upon completion of PIP BOSTON, Dec. 18, 2018 (GLOBE NEWSWIRE) -- [...]
Intra-Cellular Therapies Announces Update on ITI-007-201 Clinical Trial for Treatment of Agitation in Patients with Probable Alzheimer's Disease
18/12/2018
NEW YORK, Dec. 18, 2018 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today [...]
Anchiano Therapeutics Announces Initiation of Its Pivotal Codex Study of Inodiftagene Vixteplasmid in Patients with Non-Muscle-Invasive Bladder Cancer
18/12/2018
CAMBRIDGE, Mass., Dec. 18, 2018 (GLOBE NEWSWIRE) -- Anchiano Therapeutics ( TASE: ANCN ), a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapies to treat cancer, today [...]
Wiz Khalifa Partners with Supreme to Expand Cannabis Brand -- CFN Media
18/12/2018
SEATTLE, Dec. 18, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]
Crown Bioscience Creates Center of Excellence for Bioinformatics, Big Data, and Biomarker Discovery Services
18/12/2018
Services and Capacity Increase with New Site Opening SAN DIEGO, Dec. 18, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience, a global drug discovery and development services company providing translational platforms to advance [...]
Assure Holdings Performs First Neuromonitoring Case in Michigan
18/12/2018
Assure Continues Expansion, Now Operating in Six States DENVER, Dec. 18, 2018 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “ Company ” or “ Assure ”) (TSXV: IOM; OTCPK: ARHH), a provider of intraoperative [...]
Portola Pharmaceuticals to Webcast Corporate Update on January 8, 2019
18/12/2018
SOUTH SAN FRANCISCO, Calif., Dec. 18, 2018 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc. ® (Nasdaq: PTLA) today announced that Scott Garland, Portola’s president and chief executive officer, will provide a corporate [...]
2018 Farm Bill Nears Passage For Hemp Based CBD Products Creating Tremendous Opportunity For PSIQ
18/12/2018
PSIQ POSITIONED TO SUBSTANTIALLY EXPAND ITS HEMP BASED CBD OPERATION WITH THE PASSAGE OF THE 2018 FARM BILL PSIQ SEEKS TO JUMP TO THE TOP TIER OF HEMP BASED CBD COMPANIES WITH THE PASSAGE OF THE 2018 FARM BILL SUNRISE, [...]
Cynata Completes Clinical Study Report for Phase 1 Trial of CYP-001 in GvHD
18/12/2018
MELBOURNE, Australia, Dec. 18, 2018 (GLOBE NEWSWIRE) -- Cynata Therapeutics Limited (ASX: CYP), a clinical-stage biotechnology company specializing in cell therapeutics, is pleased to announce that the clinical study [...]
Agile Therapeutics to Present at Biotech Showcase 2019
18/12/2018
PRINCETON, N.J., Dec. 18, 2018 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, announced today that its Chairman and Chief Executive Officer, Al Altomari will present at the [...]
Palvella Therapeutics Announces $10 Million in Funding from Ligand Pharmaceuticals to Accelerate PTX-022 through Phase 2/3 Clinical Study in Pachyonychia Congenita
18/12/2018
Fast Track-Designated Program Commencing Phase 2/3 Study in Q1 2019 Wayne, PA, Dec. 18, 2018 (GLOBE NEWSWIRE) -- Palvella Therapeutics, Inc., a rare disease biopharmaceutical company focused on developing and [...]
Delcath Announces 4th Independent Safety Review of Registration Trial Data for Metastatic Ocular Melanoma: Recommended Continuation with no Trial Modification
18/12/2018
Trial Continues on Scheduled Path with Expected Completion of Enrollment by June 2019 NEW YORK, Dec. 18, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB: DCTH), an interventional oncology company focused on the [...]
VBI Vaccines Announces Closing of Public Offering of Common Stock and Partial Exercise of Underwriter’s Option to Purchase Additional Shares for Aggregate Gross Proceeds of $42.9 Million
18/12/2018
CAMBRIDGE, Mass., Dec. 18, 2018 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, today [...]
HealthLynked Announces Agreement with Availity, the Nation’s Largest Health Benefits Network, to Deliver HealthLynked Members Real-time Benefit Information
18/12/2018
NAPLES, Fla., Dec. 18, 2018 (GLOBE NEWSWIRE) -- HealthLynked Corp. (OTCQB: HLYK) today announced the company has entered into a master trading partner agreement with Availity, a leader in real-time information [...]
InspireMD Announces Publication of Meta-Analysis Citing Benefits of Next Generation Mesh-Covered Carotid Stent Systems
18/12/2018
Analysis includes clinical studies incorporating the Company’s MicroNet™-covered stent, the CGuard™ Embolic Prevention System (EPS) TEL AVIV, Israel, Dec. 18, 2018 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: [...]
Progressive Care Inc. Garners News Coverage in Leading Financial Publications, Yahoo Finance and Benzinga on Its Efforts to End the Opioid Crisis
18/12/2018
MIAMI, Dec. 18, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. ( OTCQB: RXMD ), a personalized healthcare services and technology company, today announced that it has garnered news coverage in leading financial [...]
Sport Endurance Announces Investment in Nutritional Pet Food Company, TruPet
18/12/2018
BROOKLYN, N.Y., Dec. 18, 2018 (GLOBE NEWSWIRE) -- Sport Endurance, Inc. (OTCQB: SENZ) (the “Company”), announced today that it has made a $2.2 million investment in TruPet LLC (“TruPet”), the parent company of TruDog, a [...]
Radient Technologies Inc. Announces Commencement of Trading on the OTCQX, Best Market in the United States
18/12/2018
EDMONTON, Alberta, Dec. 18, 2018 (GLOBE NEWSWIRE) -- Radient Technologies Inc. (“Radient” or the “Company”) ( TSX Venture: RTI; OTCQX: RDDTF ) is pleased to announce that its common shares commenced trading today on the [...]
OpGen Completes CDC Contract to Develop Clinical Support Mobile-Based Tools for Antimicrobial Stewardship and Infection Control
18/12/2018
GAITHERSBURG, Md., Dec. 18, 2018 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ: OPGN) today announced that it has provided the final report for completion of the contract from the Centers for Disease Control and Prevention ( [...]

Pages